Harsh represents individuals, businesses, institutional and public entity health care clients in all facets of litigation in state and federal courts, formal and informal disputes resolution methods including in arbitrations, and before administrative agencies.
Harsh also counsels and guides clients in matters involving regulatory issues, including fraud and abuse compliance, licenses and permits, as well as False Claims Act internal and government investigations and enforcement actions. Harsh often serves as the health care regulatory counsel on a variety of transactions involving state and federal agencies, including the Center for Medicare and Medicaid (CMS), California Department Health Care Services (DHCS), California Department of Public Health (CDPH), and the California State Board of Pharmacy.
Harsh’s representative matters include:
Fraud and Abuse Compliance
Assessing false claims act risk and coordinating a major health system’s internal investigation of its billing practices and its voluntary self-disclosure to the Department of Health and Human Services, Office of the Inspector General.
Providing critical analysis and health care compliance advice on a variety of business arrangements involving health plans, physicians and other providers.
Health Care Transactions
Counseling in complex transactions involving sales and acquisitions of clinics, pharmacies and hospitals; to ensure smooth transition, review, analyze and coordinate regulatory change of ownership requirement for permits and licenses, including Medicare and Medi-Cal participation, California Board of Pharmacy permit, California Department of Public Health filings, and other regulatory licenses and permits.
Health Care Litigation and Enforcement
Litigating a series of dismissals in federal court on behalf of non-profit Medicare Advantage Organization against several out-of-network hospitals’ claims for additional reimbursement for services rendered to Medicare beneficiaries.
Counseling specialty pharmacy in California state court action and related administrative appeal of the suspension of the pharmacy’s enrollment in the Medi-Cal program which resulted in the California Department of Health Care Services decision to re-enroll the pharmacy as an authorized specialty pharmacy provider.